Answers are grounded in this paper and cite their sources.
Demonstrates safe RNA delivery in lung tissues, suggesting broad therapeutic applications.
) of approximately 0.05 mg/kg. Taken together, these findings establish Lipid-392 stLNP as a safe, efficient, and versatile platform for lung-targeted RNA delivery with broad therapeutic potential for various diseases and promising translational applications.
No takes yet. Share an insight, caveat, or question.
Fei et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: